Cargando…

Association between Hoehn and Yahr, Mini-Mental State Examination, age, and clinical syndrome predominance and diagnostic effectiveness of ioflupane I 123 injection (DaTSCAN™) in subjects with clinically uncertain parkinsonian syndromes

INTRODUCTION: Diagnostic effectiveness of Ioflupane I 123 injection (DaTSCAN™, DaTscan™, or [123I]FP-CIT or ioflupane [(123)I]) SPECT imaging, was assessed in patients with clinically uncertain parkinsonian syndrome (CUPS). METHODS: We investigated the association between subject’s Hoehn & Yahr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bajaj, Nin, Hauser, Robert A, Seibyl, John, Kupsch, Andreas, Plotkin, Michail, Chen, Chris, Grachev, Igor D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255542/ https://www.ncbi.nlm.nih.gov/pubmed/25478029 http://dx.doi.org/10.1186/s13195-014-0067-0

Ejemplares similares

Rest Tremor Pattern Predicts DaTscan ( (123)I‐Ioflupane) Result in Tremulous Disorders
por: Quattrone, Andrea, et al.
Publicado: (2021)

Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with ((123)I) ioflupane in diagnosis of parkinsonian syndromes
por: Bajaj, Nin, et al.
Publicado: (2013)

Clinical utility of DaTscan in patients with suspected Parkinsonian syndrome: a systematic review and meta-analysis
por: Bega, Danny, et al.
Publicado: (2021)

Impact of DaTscan Imaging on Clinical Decision Making in Clinically Uncertain Parkinson’s Disease
por: Isaacson, Jonathan R., et al.
Publicado: (2021)

CADA—computer-aided DaTSCAN analysis
por: Augimeri, Antonio, et al.
Publicado: (2016)

Association between body mass index (BMI) and [(123)I]Ioflupane (DaTSCAN) availabilities in patients with parkinsonism using single-photon emission computed tomography–computed tomography (SPECT-CT)
por: Parekh, Puja, et al.
Publicado: (2023)

(123)I-ioflupane brain SPECT and (123)I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders
por: Nuvoli, Susanna, et al.
Publicado: (2017)

Changes in Cortical Thickness in Patients With Early Parkinson’s Disease at Different Hoehn and Yahr Stages
por: Gao, Yuyuan, et al.
Publicado: (2018)

Total Cerebral Small Vessel Score Association With Hoehn and Yahr Stage in Parkinson’s Disease
por: Ma, Xinxin, et al.
Publicado: (2021)

Hoehn and Yahr Stage and Striatal Dat-SPECT Uptake Are Predictors of Parkinson’s Disease Motor Progression
por: Jackson, Holly, et al.
Publicado: (2021)

Time Taken for and Causes of a Decline to Hoehn and Yahr Stage 5 in Patients with Parkinson's Disease
por: Kashihara, Kenichi, et al.
Publicado: (2022)

Positive FP-CIT SPECT (DaTSCAN) in Clinical Alzheimer's Disease – An Unexpected Finding?
por: Bittner, Verena, et al.
Publicado: (2011)

Association between Fatigue and Hoehn-Yahr Staging in Parkinson’s Disease: Eight-Year Follow-Up Study
por: Kataoka, Hiroshi, et al.
Publicado: (2021)

An Ensemble of CNN Models for Parkinson’s Disease Detection Using DaTscan Images
por: Kurmi, Ankit, et al.
Publicado: (2022)

Parkinsonism Associated with Pathological 123I-FP-CIT SPECT (DaTSCAN) Results as the Initial Manifestation of Sporadic Creutzfeldt-Jakob Disease
por: Carrasco García de León, Sira, et al.
Publicado: (2018)

Impact of the cerebrospinal fluid-mask algorithm on the diagnostic performance of (123)I-Ioflupane SPECT: an investigation of parkinsonian syndromes
por: Iwabuchi, Yu, et al.
Publicado: (2019)

The subresolution DaTSCAN phantom: a cost-effective, flexible alternative to traditional phantom technology
por: Taylor, Jonathan C., et al.
Publicado: (2018)

Is nigrostriatal dopaminergic deficit necessary for Holmes tremor to develop? The DaTSCAN and IBZM SPECT study
por: Gajos, Agata, et al.
Publicado: (2017)

Exploring the Effects of Genetic Variants on Clinical Profiles of Parkinson’s Disease Assessed by the Unified Parkinson’s Disease Rating Scale and the Hoehn–Yahr Stage
por: Shi, Chen, et al.
Publicado: (2016)

Genome- and Exome-Wide Association Studies Revealed Candidate Genes Associated with DaTscan Imaging Features
por: Yaghoobi, Arash, et al.
Publicado: (2023)

No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [(123)I]FP-CIT (DaTSCAN) and SPECT
por: Thomsen, Gerda, et al.
Publicado: (2013)

Differences in Home Health Nursing Care for Patients with Parkinson's Disease by Stage of Progress: Patients in Hoehn and Yahr Stages III, IV, and V
por: Iwasa, Yumi, et al.
Publicado: (2021)

Machine Learning for Early Parkinson’s Disease Identification within SWEDD Group Using Clinical and DaTSCAN SPECT Imaging Features
por: Khachnaoui, Hajer, et al.
Publicado: (2022)

Efficacy of Rotigotine at Different Stages of Parkinson’s Disease Symptom Severity and Disability: A Post Hoc Analysis According to Baseline Hoehn and Yahr Stage
por: Giladi, Nir, et al.
Publicado: (2016)

CT-Based Attenuation Correction in I-123-Ioflupane SPECT
por: Lange, Catharina, et al.
Publicado: (2014)

Accelerated high frequency rTMS induces time-dependent dopaminergic alterations: a DaTSCAN brain imaging study in healthy beagle dogs
por: Xu, Yangfeng, et al.
Publicado: (2023)

Is ioflupane I123 injection diagnostically effective in patients with movement disorders and dementia? Pooled analysis of four clinical trials
por: O'Brien, John T, et al.
Publicado: (2014)

Patient Survey on Satisfaction and Impact of 123I-Ioflupane Dopamine Transporter Imaging
por: Covington, Matthew F., et al.
Publicado: (2015)

Interpreting (123)I–ioflupane dopamine transporter scans using hybrid scores
por: Nichols, Kenneth J., et al.
Publicado: (2018)

Safety, biodistribution and radiation dosimetry of [(123)I]ioflupane in healthy Chinese volunteers
por: Zhang, Min, et al.
Publicado: (2023)

Diagnostic accuracy of (18)F-FP-CIT PET for clinically uncertain Parkinsonian syndrome
por: Oh, Minyoung, et al.
Publicado: (2023)

Discriminating among degenerative parkinsonisms using advanced (123)I-ioflupane SPECT analyses
por: Badoud, Simon, et al.
Publicado: (2016)

Comparison of [(18)F]-FDOPA PET and [(123)I]-FP-CIT SPECT acquired in clinical practice for assessing nigrostriatal degeneration in patients with a clinically uncertain parkinsonian syndrome
por: Wallert, Elon, et al.
Publicado: (2022)

Bipolar Disorder and Parkinson's Disease: A (123)I-Ioflupane Dopamine Transporter SPECT Study
por: Erro, Roberto, et al.
Publicado: (2021)

No impact of attenuation and scatter correction on the interpretation of dopamine transporter SPECT in patients with clinically uncertain parkinsonian syndrome
por: Schiebler, Tassilo, et al.
Publicado: (2023)

Diagnosis of Parkinson syndrome and Lewy-body disease using (123)I-ioflupane images and a model with image features based on machine learning
por: Nakajima, Kenichi, et al.
Publicado: (2022)

Comparison between Different Intensity Normalization Methods in (123)I-Ioflupane Imaging for the Automatic Detection of Parkinsonism
por: Brahim, A., et al.
Publicado: (2015)

Clinical Comparison of (99m)Tc Exametazime and (123)I Ioflupane SPECT in Patients with Chronic Mild Traumatic Brain Injury
por: Newberg, Andrew B., et al.
Publicado: (2014)

The role of (123)I-ioflupane SPECT dopamine transporter imaging in the diagnosis and treatment of patients with dementia with Lewy bodies
por: Antonini, Angelo
Publicado: (2007)

Correction: Comparison between Different Intensity Normalization Methods in (123)I-Ioflupane Imaging for the Automatic Detection of Parkinsonism
por: Brahim, A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_k868l91hdtbbisi3gmsunipjvf